Clinical Trial Update: Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a prolonged-release formulation of torasemide for its effect on myocardial fibrosis in patients with heart failure; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Torasemide Prolonged-Release (torasemide)

Snippet

Sponsor: Ferrer Internacional S.A. | Conditions: Congestive Heart Failure | Phase 4 | Status: COMPLETED